Usman Nassim

Gyre Therapeutics, Inc. · Director

Usman Nassim is listed in filings as Director at Gyre Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jul 1, 2024, including sale activity. Recent filings connect the profile to Gyre Therapeutics, Inc. (GYRE). The current snapshot covers public activity from Jul 1, 2024. Reported amounts are shown as $41.4K to $23.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

Latest Trades

CompanyValueActionPriceLast Price
Gyre Therapeutics, Inc.GYRE$41k3.5k sharesSellJun 28, 2024$12.00$5.74